Obsidian Therapeutics

1030 Massachusetts Avenue
Suite 400
Cambridge
Massachusetts
02138
United States

Email: info@obsidiantx.com

Show jobs for this employer

About Obsidian Therapeutics

Obsidian Therapeutics, founded in 2015, aspires to extend adoptive immunotherapy to every patient with cancer. We do this by building cell therapies with pharmacologic operating systems to provide treating physicians with precise and dynamic control of engineered cells in patients. ​

YEAR FOUNDED:
2015

LEADERSHIP:
CEO: Michael Gilman, PhD
Sr. VP and Head of Business Operations: Tariq Kassum, MD
Sr. VP and Head of Research: Steve Shamah, PhD
VP, Discovery: Vipin Suri, PhD
VP, Cell Discovery: Celeste Richardson, PhD
Sr. Advisor: Mike Briskin, PhD

CAREER:
Please click here for Obsidian Therapeutics' job opportunities.

14 articles with Obsidian Therapeutics